ZyVersa Therapeutics Inc (ZVSA)

ZyVersa Therapeutics Inc (ZVSA) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	81.80% -0.000101	-0.000555	-0.00021	-0.000314	0.00108
Operating Expenses	79.71% 2.8266	13.93	2.9027	86.33	4.5921
Benefits Costs and Expenses	2.8266	-	2.9027	86.33	-
Costs And Expenses	2.8266	-	2.9027	86.33	4.5932
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	79.71% -2.8266	-13.93	-2.9027	-86.33	-4.5921
Net Interest Income/Expense	-0.000101	-	-0.00021	-0.000314	0.00108
Interest Income/Expense After Provision For Losses	-0.000101	-	-0.00021	-0.000314	0.00108
Income/Loss From Continuing Operations Before Tax	79.71% -2.8267	-13.93	-2.9029	-86.33	-3.544
Income/Loss From Continuing Operations After Tax	87.60% -2.8267	-22.79	-2.9024	-78.51	-3.544
Net Income/Loss	78.81% -2.8267	-13.34	-2.9024	-78.51	-3.544
Preferred Stock Dividends And Other Adjustments	100.00% -	-7.9158	0.0843	7.9158	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	103.38% 0.6236	-18.43	30.98	17.86	9.1285
Diluted Average Shares	103.38% 0.6236	-18.43	30.98	17.86	-4.3384
Basic Earnings Per Share	95.65% -4.53	-104.18	-0.09	-4.84	-0.39
Diluted Earnings Per Share	95.65% -4.53	-104.18	-0.09	-4.84	-1.82
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	100.00% -	-7.9158	0.0843	-	-